Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of CD164 on Malignant T cells in Sézary Syndrome.

Acta dermato-venereologica - 1 May 2016

Guenova Emmanuella, Ignatova Desislava, Chang Yun-Tsan, Contassot Emmanuel, Mehra Tarun, Saulite Ieva, Navarini Alexander A, Mitev Vanyo, Dummer Reinhard, Kazakov Dmitry V, French Lars E, Hoetzenecker Wolfram, Cozzio Antonio

Abstract excerpt

Sézary syndrome is a primary cutaneous T-cell lymphoma characterized by pruritic erythroderma, peripheral lymphadenopathy and the presence of malignant T cells in the blood. Unequivocal detection of malignant cells in patients with Sézary syndrome is of important diagnostic, prognostic and therapeutic value. However, no single Sézary syndrome specific cell surface marker has been identified. In a cohort of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dipeptidyl Peptidase 4
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to CD4-Positive T-Lymphocytes

Share to Cells, Cultured

Share to Flow Cytometry

Share to Immunophenotyping

Share to Skin Neoplasms

Share to Treatment Outcome

Source

Identifiers

PMID: 26524186
DOI: 10.2340/00015555-2264

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of CD164 on Malignant T cells in Sézary Syndrome.PMID 26524186Read ↗

Improved Sézary cell detection and novel insights into immunophenotypic and molecular heterogeneity in Sézary syndromeSemantic proximity Read ↗

Significance of circulating T-cell clones in Sezary syndrome.Semantic proximity Read ↗

Sézary syndrome: old enigmas, new targets.Semantic proximity Read ↗

CD158k Is a Reliable Marker for Diagnosis of Sézary Syndrome and Reveals an Unprecedented Heterogeneity of Circulating Malignant CellsSemantic proximity Read ↗

CD158k and PD-1 expressions define heterogeneous subtypes of Sezary syndromeSemantic proximity Read ↗

Sézary Syndrome: Translating Genetic Diversity into Personalized Medicine.Semantic proximity Read ↗

Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3Semantic proximity Read ↗

Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes.Semantic proximity Read ↗

CD158k/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome.Semantic proximity Read ↗

Utility of combined CD39/CD73/CD38 expression for the detection of malignant T cells in Sézary syndrome.Semantic proximity Read ↗

Identification of Gene Mutations and Fusion Genes in Patients with Sézary Syndrome.Semantic proximity Read ↗

Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.